Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-25-041238
Filing Date
2025-08-28
Accepted
2025-08-28 06:47:31
Documents
5
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 6-K a6-kformhy2025hyonly.htm 6-K 16985
2 EX-99.1 a991pressreleasehy2025-hyo.htm EX-99.1 67229
3 EX-99.2 a992interimmanagementrepor.htm EX-99.2 174261
4 EX-99.3 a993062025jun20256kprtcsem.htm EX-99.3 700125
5 sharonbarbersignaturea.jpg GRAPHIC 7290
  Complete submission text file 0001628280-25-041238.txt   969165
Mailing Address 6 TIDE STREET SUITE 400 BOSTON MA 02210
Business Address 6 TIDE STREET SUITE 400 BOSTON MA 02210 617-482-2333
PureTech Health plc (Filer) CIK: 0001782999 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39670 | Film No.: 251267419
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)